LOS ANGELES (AP) _ Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $14.2 million in its third quarter.
On a per-share basis, the Los Angeles-based company said it had a loss of 37 cents.
The biopharmaceutical company posted revenue of $62.6 million in the period.
Puma Biotech shares have dropped 61 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $38.60, a fall of 69 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI